Clinical Trials Directory

Trials / Completed

CompletedNCT02781987

Incidence and Risk Factor of Post-ERCP Pancreatitis in Chronic Pancreatitis

Changhai Hospital, the Second Military Medical University

Status
Completed
Phase
Study type
Observational
Enrollment
2,028 (actual)
Sponsor
Changhai Hospital · Academic / Other
Sex
All
Age
5 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the incidence of post-ERCP pancreatitis (PEP) in chronic pancreatitis (CP) patients to that in biliary disease patients, to determine whether CP patients in early clinical stage have a higher PEP incidence, and to identify the predictive and protective factors for PEP in chronic pancreatitis patients.

Detailed description

Analysis of patients with chronic pancreatitis (CP group) and biliary disease (BD group) in Changhai Hospital from January 2011 to May 2015 were conducted. Difference of PEP incidences between BD group and CP group, as well as between M-ANNHEIM subcategories were calculated by chi-square test or Fisher's exact test. The predictive and protective factors for PEP were investigated by univariate and multivariate analysis.

Conditions

Interventions

TypeNameDescription
OTHERchronic pancreatitispatients with chronic pancreatitis

Timeline

Start date
2011-01-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2016-05-25
Last updated
2017-01-13

Source: ClinicalTrials.gov record NCT02781987. Inclusion in this directory is not an endorsement.